EmVenio Insights
Explore our resources, including blogs, whitepapers, press, videos, and more.
">EmVenio Research adds principal investigators to research team
Please join us in welcoming Dr. Stephen Blank, M.D., and Dr. Suzanne Swan, M.D., who’ve joined our team as principal investigators. In their roles, they will oversee and conduct objective clinical research to ensure independent, high quality and reproducible results,…
">EmVenio Research and TrialHub partner to optimize patient participation and accelerate site selection for clinical trials
EmVenio Research has partnered with TrialHub to conduct a wider range of clinical trials for new life-saving treatments.
">
">EmVenio Research expands internationally with 10 research sites in the U.K.
U.S.-based researcher and EMS Healthcare collaborate to conduct commercial clinical trials through a network of mobile research sites. DURHAM, N.C., June 20, 2023 – Community research provider EmVenio Research today announced its international expansion with the launch of research operations…
">Juneteenth 2023
Juneteenth, also known as Freedom Day or Emancipation Day, is an annual holiday celebrated on June 19th in the United States. This day signifies the legal abolition of slavery in the nation and honors the emancipation of enslaved African Americans.…
">EmVenio Research May 2023 Community Engagement Overview
Author: Tomas Herrera At EmVenio Research, we strongly believe that a successful company is not just about profits and growth, but also about building meaningful connections with the communities it serves. And the month of May was no exception! We…
">EmVenio Research establishes advisory board
Esteemed pharmaceutical leader Dr. Neil Kurtz appointed to board chair DURHAM, N.C., June 1, 2023 – Clinical trial organization EmVenio Research today announced the inception of an advisory board of veteran industry leaders. The board will provide strategic oversight and…
">Webinar: Bringing Clinical Trial Access to Underserved Populations in a Community Setting
Clinical trials are an important healthcare option, presenting benefits to patients, physicians and the broader community. Yet, relatively low enrollment rates have continued to be a bottleneck for clinical trials. In traditional research settings, about four percent of the US…
EmVenio Research prioritizes improving access to clinical research in Chicago with opening of community research site
DURHAM, N.C., May 18, 2023 /PRNewswire/ — EmVenio Research activated a mobile community research site in Chicago, Illinois, on the Illinois Medical District campus as part of a concerted effort to maximize diversity, equity and inclusion in research studies and deliver clinical trial access to…
">EmVenio Research and Socially Determined partner to optimize recruitment, retention and representation in clinical trials
Durham, NC – May 17, 2023 – EmVenio Research, a company providing rapid and scalable mobile research sites in order to better reach and recruit diverse, underserved and high-risk communities, has partnered with Socially Determined, a social risk analytics and data…
">World Vaccine Congress 2023
EmVenio Research attended the World Vaccine Congress in Washington DC earlier this month. The conference, which took place from April 3rd to 6th, brought together industry leaders, scientists, and researchers from around the world to discuss the latest advancements in…
">EmVenio Research March 2023 Community Engagement Overview
EmVenio Research’s dedication to the community is demonstrated by action. Our passion for engaging local communities is what sets us apart. On March 6th, our mobile Community Research Site was on campus! The students from Georgia Tech School of Industrial…